Acorda Therapeutics reported $-4969000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Acorda Therapeutics ACOR:US $ -4.97M 3.28M
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
ALKERMES ALKS:US $ -7.39M 30.91M
Amgen AMGN:US $ 3341M 185M
Anika Therapeutics ANIK:US $ 0.06M 5.22M
Aptinyx Inc APTX:US $ -19279000 207K
Arrowhead Research ARWR:US $ 44.15M 104.9M
Biogen BIIB:US $ 674.7M 20.2M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Cara Therapeutics CARA:US $ -27848000 5.61M
Clovis Oncology CLVS:US $ -48.44M 2.28M
Cytokinetics CYTK:US $ -76.52M 58.35M
Enanta Pharmaceuticals ENTA:US $ -33.02M 3.4M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Insmed INSM:US $ -98173000 1.78M
Ligand Pharmaceuticals LGND:US $ 4.35M 21.55M
Mannkind MNKD:US $ -21.92M 2.4M
Merck MRK:GR € 1630M 173M
Moderna Inc MRNA:US 4.31B 1.18B
Neurocrine Biosciences NBIX:US $ 6.4M 60.6M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Teva Pharmaceutical TEVA:IT 1.11B 176M
Ultragenyx Pharmaceutical RARE:US $ -132.54M 33.51M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M